Product name:Pirenoxine
CAS: 1043-21-6
Molecular Formula: C16H8N2O5
Molecular Weight: 308.25
Product description:The goods for the prevention and treatment of cataract. Can improve the metabolic abnormalities of aromatic amino acid, inhibit quinone compounds, which is stable for crystal opacity or postpone the development effect. Attending senile cataracts, diabetic cataract, can also be used in the treatment of traumatic cataract and congenital cataract. In addition, has certain influence to the adjustment function, have to suppress the effect of vision loss or improve vision. Stop within the goods sodium salt (white) in mice, oral LD50 is greater than 10000 mg/kg, subcutaneous injection of more than 5000 mg/kg, intraperitoneal injection of 2120-2250 mg/kg; In rats, intraperitoneal injection, male is 2400 mg/kg, the female is 1460 mg/kg.